跳至主要内容
临床试验/JPRN-UMIN000000504
JPRN-UMIN000000504已完成2 期

The safety and efficacy trial of sequential administration with AP (Doxorubicin/Paclitaxel) followed by weekly Paclitaxel as preoperative chemotherapy for breast cancer: SBCCSG-07 - The safety and efficacy trial of sequential administration with AP (Doxorubicin/Paclitaxel) followed by weekly Paclitaxel as preoperative chemotherapy for breast cancer: SBCCSG-07

Saitama Breast Cancer Clinical Study Group (SBCCSG)0 个研究点目标入组 30 人开始时间: 2006年10月30日最近更新:

试验速览

阶段
2 期
状态
已完成
发起方
入组人数
30

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
20years-old 至 70years-old(—)
性别
Female

入选标准

  • 未提供

排除标准

  • 1. severe complication 2. suspicious of infection 3. past history of allergic reaction to cremophor EL (polyoxyethylated caster oil) or polysorbate 4. Pregnant or lactating women 5. Doctor's decision for exclusion

研究者

发起方
Saitama Breast Cancer Clinical Study Group (SBCCSG)

相似试验

进行中(未招募)
1 期
Safety and preliminary efficacy of sequential multiple ascending doses of solnatide to treat pulmonary permeability oedema in patients with moderate-to-severe ARDS - a randomised, placebo-controlled, double-blind trialpulmonary permeability oedema in patients with moderate-to-severe ARDSMedDRA version: 21.1Level: LLTClassification code 10003083Term: ARDSSystem Organ Class: 10038738 - Respiratory, thoracic and mediastinal disordersMedDRA version: 20.0Level: PTClassification code 10037423Term: Pulmonary oedemaSystem Organ Class: 10038738 - Respiratory, thoracic and mediastinal disorders
EUCTR2017-003855-47-DEApeptico Forschung und Entwicklung GmbH95
进行中(未招募)
不适用
Efficacy and safety study of a sequential therapy of tocilizumab (TCZ) and, if initially inade-quately responded to tocilizumab (TCZ), followed by rituximab (RTX) in DMARD-IR patients with rheumatoid arthritis (MIRAI) - MIRAI
EUCTR2010-022049-88-DERoche Pharma AG
招募中
1 期
Clinical efficacy and safety of sequential therapy with cryotherapy and topical tirbanibulin 1% in actinic keratoses in transplant recipients: a randomised clinical trial.MedDRA version: 20.0Level: PTClassification code: 10000614Term: Actinic keratosis Class: 100000004858Actinic keratosis
CTIS2023-508091-11-00Clinica Universidad De Navarra40
已完成
4 期
comparison of effectiveness and safety of topical sequential therapy with tazarotene and calcitriol with monotherapy of calcitriol or tazarotene in patients with stable plaque psoriasis.
CTRI/2020/03/023715nil120
已完成
不适用
Clinical trial for efficacy of proactive sequential therapy using topical active Vitamin D and corticosteroids on psoriatic vulgaris
JPRN-UMIN000005814Kyushu University Hospital40